Adage Capital Partners Gp, L.l.c. - Net Worth and Insider Trading
Adage Capital Partners Gp, L.l.c. Net Worth
The estimated net worth of Adage Capital Partners Gp, L.l.c. is at least $4.0 Billion dollars as of 2024-04-28. Adage Capital Partners Gp, L.l.c. is the 10% Owner of Celanese Corp and owns about 13,588,774 shares of Celanese Corp (CE) stock worth over $2.1 Billion. Adage Capital Partners Gp, L.l.c. is the 10% Owner of Royalty Pharma PLC and owns about 38,714,280 shares of Royalty Pharma PLC (RPRX) stock worth over $1.1 Billion. Adage Capital Partners Gp, L.l.c. is also the 10% Owner of Five Prime Therapeutics Inc and owns about 5,104,898 shares of Five Prime Therapeutics Inc (FPRX) stock worth over $194 Million. Besides these, Adage Capital Partners Gp, L.l.c. also holds Mantech International Corp (MANT) , Heartware International Inc (HTWR) , ORBCOMM Inc (ORBC) , Boulder Brands Inc (BDBD) , AMAG Pharmaceuticals Inc (AMAG) , Vitae Pharmaceuticals Inc (VTAE) , GCM Grosvenor Inc (GCMG) , MuleSoft Inc (MULE) , Puma Biotechnology Inc (PBYI) , Solaris Oilfield Infrastructure Inc (SOI) , AMCI Acquisition Corp (AMCI) , Calithera Biosciences Inc (CALA) , Advaxis Inc (ADXS) . Details can be seen in Adage Capital Partners Gp, L.l.c.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Adage Capital Partners Gp, L.l.c. has not made any transactions after 2023-05-10 and currently still holds the listed stock(s).
Transaction Summary of Adage Capital Partners Gp, L.l.c.
Adage Capital Partners Gp, L.l.c. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adage Capital Partners Gp, L.l.c. owns 31 companies in total, including ORBCOMM Inc (ORBC) , Royalty Pharma PLC (RPRX) , and Protagonist Therapeutics Inc (PTGX) among others .
Insider Ownership Summary of Adage Capital Partners Gp, L.l.c.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ORBC | ORBCOMM Inc | 2020-08-12 | 10 percent owner |
RPRX | Royalty Pharma PLC | 2020-12-18 | 10 percent owner |
PTGX | Protagonist Therapeutics Inc | 2017-05-30 | 10 percent owner |
SOI | Solaris Oilfield Infrastructure Inc | 2017-05-12 | 10 percent owner |
ADXS | Advaxis Inc | 2017-10-11 | 10 percent owner |
CALA | Calithera Biosciences Inc | 2017-09-28 | 10 percent owner |
PBYI | Puma Biotechnology Inc | 2017-06-12 | 10 percent owner |
MULE | MuleSoft Inc | 2017-03-17 | 10 percent owner |
VTAE | Vitae Pharmaceuticals Inc | 2016-09-14 | 10 percent owner |
PSUNQ | Pacific Sunwear of California Inc | 2016-04-05 | 10 percent owner |
FPRX | Five Prime Therapeutics Inc | 2015-10-15 | 10 percent owner |
HTWR | Heartware International Inc | 2015-08-03 | 10 percent owner |
NVET | Nexvet Biopharma PLC | 2015-02-10 | 10 percent owner |
AMAG | AMAG Pharmaceuticals Inc | 2015-01-07 | 10 percent owner |
CNCE | Concert Pharmaceuticals Inc | 2014-02-12 | 10 percent owner |
IGOI | iGo Inc | 2013-08-28 | 10 percent owner |
BDBD | Boulder Brands Inc | 2013-02-01 | 10 percent owner |
FNCX | Function(x) Inc | 2012-07-31 | 10 percent owner |
APPS | Digital Turbine Inc | 2012-03-01 | other: The Reporting Persons are no l |
SNBR | Sleep Number Corp | 2008-11-21 | 10 percent owner |
CORV | Correvio Pharma Corp | 2010-04-14 | 10 percent owner |
CE | Celanese Corp | 2009-02-02 | 10 percent owner |
HUB.A | Hubbell Inc | 2008-04-25 | 10 percent owner |
MANT | Mantech International Corp | 2005-05-05 | 10 percent owner |
HUBB | Hubbell Inc | 2007-10-26 | 10 percent owner |
ADN | Advent Technologies Holdings Inc | 2020-05-15 | 10 percent owner |
GCMG | GCM Grosvenor Inc | 2023-05-10 | 10 percent owner |
ERES | East Resources Acquisition Co | 2022-07-25 | 10 percent owner |
ERESU | East Resources Acquisition Co | 2022-07-25 | 10 percent owner |
ABEO | Abeona Therapeutics Inc | 2023-07-03 | 10 percent owner |
ABL | Abacus Life Inc | 2022-07-25 | 10 percent owner |
Adage Capital Partners Gp, L.l.c. Latest Holdings Summary
Adage Capital Partners Gp, L.l.c. currently owns a total of 16 stocks. Among these stocks, Adage Capital Partners Gp, L.l.c. owns 13,588,774 shares of Celanese Corp (CE) as of February 2, 2009, with a value of $2.1 Billion and a weighting of 52.33%. Adage Capital Partners Gp, L.l.c. owns 38,714,280 shares of Royalty Pharma PLC (RPRX) as of December 18, 2020, with a value of $1.1 Billion and a weighting of 27.02%. Adage Capital Partners Gp, L.l.c. also owns 5,104,898 shares of Five Prime Therapeutics Inc (FPRX) as of October 15, 2015, with a value of $194 Million and a weighting of 4.84%. The other 13 stocks Mantech International Corp (MANT) , Heartware International Inc (HTWR) , ORBCOMM Inc (ORBC) , Boulder Brands Inc (BDBD) , AMAG Pharmaceuticals Inc (AMAG) , Vitae Pharmaceuticals Inc (VTAE) , GCM Grosvenor Inc (GCMG) , MuleSoft Inc (MULE) , Puma Biotechnology Inc (PBYI) , Solaris Oilfield Infrastructure Inc (SOI) , AMCI Acquisition Corp (AMCI) , Calithera Biosciences Inc (CALA) , Advaxis Inc (ADXS) have a combined weighting of 15.81% among all his current holdings.
Latest Holdings of Adage Capital Partners Gp, L.l.c.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CE | Celanese Corp | 2009-02-02 | 13,588,774 | 154.49 | 2,099,329,695 |
RPRX | Royalty Pharma PLC | 2020-12-18 | 38,714,280 | 28.00 | 1,083,999,840 |
FPRX | Five Prime Therapeutics Inc | 2015-10-15 | 5,104,898 | 38.00 | 193,986,124 |
MANT | Mantech International Corp | 2005-05-05 | 1,734,200 | 95.98 | 166,448,516 |
HTWR | Heartware International Inc | 2015-08-03 | 1,722,969 | 57.98 | 99,897,743 |
ORBC | ORBCOMM Inc | 2020-08-12 | 7,697,220 | 11.49 | 88,441,058 |
BDBD | Boulder Brands Inc | 2013-02-01 | 5,939,492 | 11.03 | 65,512,597 |
AMAG | AMAG Pharmaceuticals Inc | 2012-03-02 | 4,135,330 | 13.75 | 56,860,788 |
VTAE | Vitae Pharmaceuticals Inc | 2016-09-14 | 2,375,000 | 21.00 | 49,875,000 |
GCMG | GCM Grosvenor Inc | 2023-05-10 | 4,158,641 | 9.34 | 38,841,707 |
MULE | MuleSoft Inc | 2017-03-17 | 675,000 | 44.57 | 30,084,750 |
PBYI | Puma Biotechnology Inc | 2017-06-12 | 3,696,580 | 5.02 | 18,556,832 |
SOI | Solaris Oilfield Infrastructure Inc | 2017-05-12 | 1,275,000 | 9.64 | 12,291,000 |
AMCI | AMCI Acquisition Corp | 2020-12-03 | 781,535 | 9.67 | 7,557,443 |
CALA | Calithera Biosciences Inc | 2017-09-28 | 177,344 | 0.02 | 3,547 |
ADXS | Advaxis Inc | 2017-10-11 | 3,417 | 0.56 | 1,896 |
Holding Weightings of Adage Capital Partners Gp, L.l.c.
Adage Capital Partners Gp, L.l.c. Form 4 Trading Tracker
According to the SEC Form 4 filings, Adage Capital Partners Gp, L.l.c. has made a total of 0 transactions in Celanese Corp (CE) over the past 5 years. The most-recent trade in Celanese Corp is the sale of 0 shares on February 2, 2009, which brought Adage Capital Partners Gp, L.l.c. around $0.
According to the SEC Form 4 filings, Adage Capital Partners Gp, L.l.c. has made a total of 1 transactions in Royalty Pharma PLC (RPRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Royalty Pharma PLC is the sale of 7,301,050 shares on December 18, 2020, which brought Adage Capital Partners Gp, L.l.c. around $321 Million.
According to the SEC Form 4 filings, Adage Capital Partners Gp, L.l.c. has made a total of 0 transactions in Five Prime Therapeutics Inc (FPRX) over the past 5 years. The most-recent trade in Five Prime Therapeutics Inc is the sale of 125,000 shares on October 15, 2015, which brought Adage Capital Partners Gp, L.l.c. around $3 Million.
More details on Adage Capital Partners Gp, L.l.c.'s insider transactions can be found in the Insider Trading History of Adage Capital Partners Gp, L.l.c. table.Insider Trading History of Adage Capital Partners Gp, L.l.c.
- 1
Adage Capital Partners Gp, L.l.c. Trading Performance
GuruFocus tracks the stock performance after each of Adage Capital Partners Gp, L.l.c.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adage Capital Partners Gp, L.l.c. is 39.37%. GuruFocus also compares Adage Capital Partners Gp, L.l.c.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Adage Capital Partners Gp, L.l.c. within 3 months outperforms 23 times out of 37 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Adage Capital Partners Gp, L.l.c.'s insider trading performs compared to the benchmark.
Performance of Adage Capital Partners Gp, L.l.c.
Average Return
123.77%
Outperforming Transactions
62%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 13.84 | 39.37 | 45.53 | 123.77 | 66.65 | 29.95 |
Relative Return to S&P 500(%) | 11.36 | 33.65 | 35.52 | 106.33 | 52.55 | 17.42 |
Adage Capital Partners Gp, L.l.c. Ownership Network
Ownership Network List of Adage Capital Partners Gp, L.l.c.
Ownership Network Relation of Adage Capital Partners Gp, L.l.c.
Adage Capital Partners Gp, L.l.c. Owned Company Details
What does ORBCOMM Inc do?
Who are the key executives at ORBCOMM Inc?
Adage Capital Partners Gp, L.l.c. is the 10 percent owner of ORBCOMM Inc. Other key executives at ORBCOMM Inc include EVP of Product Development Craig Malone , EVP and CFO Milcos Constantine , and Chief Marketing Officer Marc Eisenberg .
ORBCOMM Inc (ORBC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ORBCOMM Inc (ORBC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ORBCOMM Inc (ORBC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ORBCOMM Inc (ORBC)'s detailed insider trading history can be found in Insider Trading Tracker table.
ORBCOMM Inc Insider Transactions
Adage Capital Partners Gp, L.l.c. Mailing Address
Above is the net worth, insider trading, and ownership report for Adage Capital Partners Gp, L.l.c.. You might contact Adage Capital Partners Gp, L.l.c. via mailing address: 200 Clarendon Street, 52nd Floor, Boston Ma 02116.